The PathClear" designation means that in addition to standard sterility, endotoxin and MAP testing, the BME is tested by PCR and is clear of a battery of 31 pathogens, including LDEV. Each lot is rigorously qualified in biological performance assays. Available in reduced growth factor form, with and without phenol red, PathClear" BME is expected to be of special interest for in vivo murine research work and other work requiring BME free from viruses, bacteria and mycoplasma.
Trevigen, Inc. develops, manufactures and markets an extensive line of Cultrex® brand products for the promotion of cell growth, cellular differentiation and for the study of cancer cell behavior. For more information, see www.trevigen.com.
Press Contact: Belinda de Leon Trevigen, Inc. www.trevigen.com 301-216-2800 info@trevigen.com
